2892:TWSEFirst Financial Holding Co. Ltd. Analysis
Data as of 2026-06-18 - not real-time
NT$32.65
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
First Financial Holding is trading at the top of its 52‑week range (TWD 32.65) with the 20‑day SMA (≈29.45) well below price, indicating strong momentum, while the 14‑day RSI has surged to 80 – a classic overbought signal. The MACD line sits above its signal line (bullish) and the histogram remains positive, reinforcing short‑term upward pressure, yet volume is on a decreasing trend and the upside/downside projection shows a modest -5.4% downside risk.
Fundamentally, the bank delivers robust operating margins (≈54%) and a healthy profit margin (≈39%) alongside 13% revenue growth, but its operating cash flow is sharply negative and debt levels are sizable, offsetting the attractive PE of 17.5 (slightly above the industry average of 17.1) and a low beta of 0.22. The extreme greed sentiment (Fear‑Greed Index 88.5) and the lack of dividend further suggest that price appreciation, not income, is the primary driver for investors.
Fundamentally, the bank delivers robust operating margins (≈54%) and a healthy profit margin (≈39%) alongside 13% revenue growth, but its operating cash flow is sharply negative and debt levels are sizable, offsetting the attractive PE of 17.5 (slightly above the industry average of 17.1) and a low beta of 0.22. The extreme greed sentiment (Fear‑Greed Index 88.5) and the lack of dividend further suggest that price appreciation, not income, is the primary driver for investors.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- RSI at 80 indicating overbought conditions
- Price approaching resistance at TWD 32.8
- Decreasing volume trend lowering short‑term support
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- 13% revenue growth and strong operating margins
- Bullish MACD and low beta suggesting stable price trends
- Valuation near industry PE average with modest upside potential
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Low beta (0.22) indicating limited systematic risk
- Sustained profitability despite negative cash flow
- High regulatory scrutiny and sizable debt requiring monitoring
Key Metrics & Analysis
Financial Health
Revenue Growth13.20%
Profit Margin39.07%
P/E Ratio17.5
ROE9.98%
ROA0.58%
P/B Ratio1.6
Op. Cash FlowNT$-333264879616
Industry P/E17.1
Technical Analysis
TrendBullish
RSI80.0
SupportNT$27.20
ResistanceNT$32.80
MA 20NT$29.45
MA 50NT$29.03
MA 200NT$28.99
MACDBullish
VolumeDecreasing
Fear & Greed Index88.5
Valuation
Target PriceNT$30.90
Upside/Downside-5.36%
GradeFair
TypeBlend
Risk Assessment
Beta0.22
Volatility25.23%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.